query,KEGG_id,KEGG_name,KEGG_formula,KEGG_pathway,KEGG_module,KEGG_brite,KEGG_enzyme,KEGG_reaction
1-Tetracosanol NIST,NA,NA,NA,NA,NA,NA,NA,NA
beta-Sitosterol NIST,C01753,beta-Sitosterol,NA,Steroid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of terpenoids and steroids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,NA,NA
D-glucuronic acidM,NA,NA,NA,NA,NA,NA,NA,NA
Docosanol NIST,NA,NA,NA,NA,NA,NA,NA,NA
hydrocinnamic acid,C05629,3-Phenylpropionic acid,C9H10O2,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine",NA,1.1.1.110;1.1.1.237;1.4.1.20;1.4.3.2;1.4.5.1;1.13.11.27;2.1.1.281;2.3.3.-;2.6.1.1;2.6.1.5;2.6.1.9;2.6.1.21;2.6.1.28;2.6.1.57;2.6.1.58;2.6.1.64;2.6.1.70;2.6.1.-;4.1.1.43;4.1.1.-;4.2.1.51;4.2.1.91;5.3.2.1,R00688 R00689 R00692 R00694 R00695 R01370 R01371 R01372;R01373 R01374 R01375 R01376 R01377 R01378 R01582 R10431;R10499 R10500 R11068
L-ornithine,cpd:C00077,"L-Ornithine;(S)-2,5-Diaminovaleric acid;(S)-2,5-Diaminopentanoic acid;(S)-2,5-Diaminopentanoate",C5H12N2O2,"Arginine biosynthesis;Arginine and proline metabolism;D-Amino acid metabolism;Glutathione metabolism;Biosynthesis of various other secondary metabolites;Biosynthesis of various antibiotics;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;ABC transporters;Efferocytosis","Proline biosynthesis, glutamate => proline;Ornithine biosynthesis, glutamate => ornithine;Urea cycle;Polyamine biosynthesis, arginine => ornithine => putrescine;Ornithine biosynthesis, mediated by LysW, glutamate => ornithine;Cycloserine biosynthesis, arginine/serine => cycloserine;Arginine biosynthesis, ornithine => arginine;Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A;Proline metabolism",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Other amino acids;    C00077  L-Ornithine,1.5.1.24;1.14.13.195;1.14.13.196;2.1.3.3;2.1.4.1;2.1.4.2;2.1.4.3;2.3.1.35;2.3.1.127;2.3.2.30;2.6.1.13;3.5.1.14;3.5.1.16;3.5.1.20;3.5.1.132;3.5.3.1;3.5.3.25;4.1.1.17;4.3.1.12;5.1.1.9;5.1.1.10;5.1.1.12,R00551 R00565 R00664 R00665 R00666 R00667 R00668 R00669;R00670 R00671 R00672 R01343 R01398 R01686 R01989 R02282;R03477 R05547 R10466 R10789 R10790 R10933 R11801 R12506
L-tyrosine,cpd:C00082,L-Tyrosine;(S)-3-(p-Hydroxyphenyl)alanine;(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid;Tyrosine,C9H11NO3,"Ubiquinone and other terpenoid-quinone biosynthesis;Monobactam biosynthesis;Tyrosine metabolism;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Novobiocin biosynthesis;Cyanoamino acid metabolism;Methane metabolism;Thiamine metabolism;Phenylpropanoid biosynthesis;Isoquinoline alkaloid biosynthesis;Betalain biosynthesis;Glucosinolate biosynthesis;Aminoacyl-tRNA biosynthesis;Biosynthesis of various other secondary metabolites;Biosynthesis of various antibiotics;Biosynthesis of various plant secondary metabolites;Biosynthesis of vancomycin group antibiotics;Biosynthesis of enediyne antibiotics;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;Dopaminergic synapse;Melanogenesis;Prolactin signaling pathway;Protein digestion and absorption;Parkinson disease;Cocaine addiction;Amphetamine addiction;Alcoholism;Central carbon metabolism in cancer","Tyrosine biosynthesis, chorismate => HPP => tyrosine;Monolignol biosynthesis, phenylalanine/tyrosine => monolignol;Tyrosine biosynthesis, chorismate => arogenate => tyrosine;Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline;Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine;Tyrosine degradation, tyrosine => homogentisate;Thiamine biosynthesis, prokaryotes, AIR (+ DXP/tyrosine) => TMP/TPP;Cyanogenic glycoside biosynthesis, tyrosine => dhurrin;C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP;Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP;Puromycin biosynthesis, ATP => puromycin;Methanofuran biosynthesis;Betacyanin biosynthesis, L-tyrosine => amaranthin",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00082  Tyrosine (Tyr);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00022)]; Chemicals;  D00022  L-Tyrosine,1.2.1.101;1.3.1.43;1.3.1.78;1.3.1.79;1.4.1.20;1.4.3.2;1.10.3.1;1.11.1.8;1.11.2.6;1.14.14.36;1.14.16.1;1.14.16.2;1.14.18.1;1.14.-.-;1.21.1.1;2.1.1.304;2.5.1.122;2.5.1.147;2.6.1.1;2.6.1.5;2.6.1.9;2.6.1.57;2.6.1.58;2.6.1.103;4.1.1.25;4.1.1.28;4.1.1.108;4.1.99.2;4.1.99.19;4.1.99.24;4.3.1.23;4.3.1.25;5.4.3.6;6.1.1.1;6.3.2.24;6.3.2.25,R00031 R00728 R00729 R00730 R00731 R00732 R00733 R00734;R00735 R00736 R00737 R00739 R01795 R01815 R02078 R02918;R03539 R04730 R05671 R06626 R06751 R07211 R07212 R08825;R09254 R09521 R09830 R10059 R10246 R10671 R10964 R10968;R11366 R11917 R12150 R12161 R12235 R12540 R12541 R12611;R12759 R13031
L-valine,cpd:C00183,L-Valine;2-Amino-3-methylbutyric acid,C5H11NO2,"Valine, leucine and isoleucine degradation;Valine, leucine and isoleucine biosynthesis;Penicillin and cephalosporin biosynthesis;Cyanoamino acid metabolism;Pantothenate and CoA biosynthesis;Glucosinolate biosynthesis;Aminoacyl-tRNA biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Mineral absorption;Central carbon metabolism in cancer","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine;Pantothenate biosynthesis, valine/L-aspartate => pantothenate;Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin;Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00183  Valine (Val);Risk category of Japanese OTC drugs [BR:br08312(D00039)]; Third-class OTC drugs;  Inorganic and organic chemicals;   L-Valine;    D00039  Valine (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00039)]; Chemicals;  D00039  L-Valine,1.4.1.8;1.4.1.9;1.4.1.23;1.14.14.38;1.14.14.39;2.6.1.6;2.6.1.32;2.6.1.42;2.6.1.66;4.1.1.14;6.1.1.9;6.3.2.26;6.3.2.47,R01212 R01214 R01215 R01434 R01437 R02200 R03665 R04870;R08663 R10031 R10941 R10942
Serratene NIST,NA,NA,NA,NA,NA,NA,NA,NA
3-Hydroxyphenylacetate,cpd:C05593,3-Hydroxyphenylacetate;3-Hydroxyphenylacetic acid,C8H8O3,Tyrosine metabolism;Phenylalanine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.14.13.63;1.14.14.9,R02515 R02517 R03299 R06791
4-Hydroxyphenylacetate,cpd:C00642,4-Hydroxyphenylacetate;4-Hydroxyphenylacetic acid,C8H8O3,Tyrosine metabolism;Phenylalanine metabolism;Degradation of flavonoids;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,Dietary phytochemicals [br08012.html]; Flavonoids;  C00642,1.2.1.5;1.2.1.29;1.2.1.39;1.2.1.53;1.2.3.13;1.14.13.18;1.14.14.9;4.1.1.83;6.2.1.-,R00042 R02514 R02516 R02695 R02697 R02698 R02699 R06790;R07312 R13086
Benzoate,cpd:C00180,Benzoate;Benzoic acid;Benzenecarboxylic acid;Phenylformic acid;Dracylic acid,C7H6O2,Benzoate degradation;Dioxin degradation;Toluene degradation;Aminobenzoate degradation;Biosynthesis of various alkaloids;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Toluene degradation, toluene => benzoate;Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate;Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",Therapeutic category of drugs in Japan [BR:br08301(D00038)]; 7  Agents not mainly for therapeutic purpose;  73  Public health agents;   731  Antiseptics;    7319  Others;     D00038  Benzoic acid (JP18/USP);Risk category of Japanese OTC drugs [BR:br08312(D00038)]; Designated second-class OTC drugs;  Inorganic and organic chemicals;   Benzoic acid;    D00038  Benzoic acid (JP18/USP); Second-class OTC drugs;  Inorganic and organic chemicals;   Benzoic acid;    D00038  Benzoic acid (JP18/USP); Third-class OTC drugs;  Inorganic and organic chemicals;   Benzoic acid;    D00038  Benzoic acid (JP18/USP);Animal drugs in Japan [BR:br08331]; 99  Agents for not mainly purpose of therapeutic;  992  Amphoteric soap and preparations;   9929  Other agents for disinfections;    C00180  Benzoate;Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00038)]; Chemicals;  D00038  Benzoic acid,1.2.1.7;1.2.1.28;1.14.12.10;1.14.13.-;1.14.14.92;2.1.1.273;3.1.1.1;3.1.1.84;3.5.1.4;3.5.1.32;3.5.1.40;3.5.5.1;3.6.1.7;3.6.1.20;3.7.1.8;6.2.1.25,R01295 R01419 R01420 R01421 R01422 R01423 R01424 R01425;R01426 R01427 R02606 R05590 R05591 R05621 R05622 R06727;R06728 R07188 R07835 R08838 R09088 R10447
Betaine,cpd:C00719,"Betaine;Trimethylaminoacetate;Glycine betaine;N,N,N-Trimethylglycine;Trimethylammonioacetate",C5H11NO2,"Glycine, serine and threonine metabolism;Metabolic pathways;ABC transporters","Betaine biosynthesis, choline => betaine;Betaine metabolism, animals, betaine => glycine;Betaine degradation, bacteria, betaine => pyruvate","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07523)]; A ALIMENTARY TRACT AND METABOLISM;  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16AA Amino acids and derivatives;     A16AA06 Betaine;      D07523  Betaine (JAN) &lt;JP/US&gt;;USP drug classification [BR:br08302(D07523)]; Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment;  Betaine;   D07523  Betaine (JAN);Therapeutic category of drugs in Japan [BR:br08301(D07523)]; 3  Agents affecting metabolism;  39  Other agents affecting metabolism;   399  Miscellaneous;    3999  Others;     D07523  Betaine (JAN);Risk category of Japanese OTC drugs [BR:br08312(D07523)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Betaine;    D07523  Betaine (JAN);New drug approvals in Europe [br08329.html(D07523)]; European public assessment reports (EPAR) authorised medicine;  D07523;New drug approvals in Japan [br08318.html(D07523)]; Drugs with new active ingredients;  D07523;New drug approvals in the USA, Europe and Japan [br08328.html(D07523)]; Approval dates by FDA, EMA and PMDA;  D07523",1.1.3.17;1.2.1.8;1.13.11.90;1.14.13.251;1.21.4.4;2.1.1.5;2.1.1.157;2.1.1.161;2.1.1.162;2.1.1.376,R02565 R02566 R02821 R07228 R07244 R08211 R08212 R10061;R10062 R12614 R12787 R13016
Fructose,cpd:C05003,D-Fructose;D-arabino-Hex-2-ulopyranose,C6H12O6,NA,NA,NA,NA,NA
O-Acetylcholine,cpd:C01996,Acetylcholine;O-Acetylcholine,C7H16NO2,Glycerophospholipid metabolism;cAMP signaling pathway;Neuroactive ligand-receptor interaction;Synaptic vesicle cycle;Cholinergic synapse;Taste transduction;Regulation of actin cytoskeleton;Insulin secretion;Salivary secretion;Gastric acid secretion;Pancreatic secretion;Bile secretion;Pathways of neurodegeneration - multiple diseases;Nicotine addiction,NA,Compounds with biological roles [BR:br08001]; Hormones and transmitters;  Neurotransmitters;   Acetylcholine;    C01996  Acetylcholine;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;    S01EB Parasympathomimetics;     S01EB09 Acetylcholine;      C01996  Acetylcholine;Drug groups [BR:br08330]; Cardiovascular agent;  DG01532  Nicotinic cholinergic receptor agonist;   DG01133  Acetylcholine;    C01996  Acetylcholine; Neuropsychiatric agent;  DG01490  Muscarinic cholinergic receptor agonist;   DG01133  Acetylcholine;    C01996  Acetylcholine; Ophthalmic agent;  DG03201  Intraocular pressure lowering agent;   DG01133  Acetylcholine;    C01996  Acetylcholine; Metabolizing enzyme substrate;  DG02974  ACHE substrate;   DG01133  Acetylcholine;    C01996  Acetylcholine,2.3.1.6;3.1.1.7;3.1.1.8,R01023 R01026
Phenylalanine,cpd:C00079,L-Phenylalanine;(S)-alpha-Amino-beta-phenylpropionic acid,C9H11NO2,"Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Cyanoamino acid metabolism;D-Amino acid metabolism;Phenylpropanoid biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Glucosinolate biosynthesis;Aminoacyl-tRNA biosynthesis;Biosynthesis of various alkaloids;Biosynthesis of various other secondary metabolites;Biosynthesis of various plant secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Mineral absorption;Central carbon metabolism in cancer","Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine;Monolignol biosynthesis, phenylalanine/tyrosine => monolignol;Flavanone biosynthesis, phenylalanine => naringenin;Ditryptophenaline biosynthesis, tryptophan + phenylalanine => ditryptophenaline;Phenylalanine biosynthesis, chorismate => arogenate => phenylalanine",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00079  Phenylalanine (Phe);Risk category of Japanese OTC drugs [BR:br08312(D00021)]; Third-class OTC drugs;  Inorganic and organic chemicals;   L-Phenylalanine;    D00021  Phenylalanine (USP/INN);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00021)]; Chemicals;  D00021  L-Phenylalanine,1.4.1.20;1.4.3.2;1.11.1.21;1.13.12.9;1.14.14.40;1.14.16.1;1.14.16.7;2.3.1.53;2.6.1.1;2.6.1.5;2.6.1.9;2.6.1.28;2.6.1.57;2.6.1.58;2.6.1.64;2.6.1.70;2.6.1.-;3.4.17.23;4.1.1.28;4.1.1.53;4.1.1.109;4.2.1.51;4.2.1.91;4.3.1.24;4.3.1.25;5.1.1.11;5.4.3.10;5.4.3.11;6.1.1.20;6.3.2.40;6.3.2.-,R00686 R00688 R00689 R00690 R00691 R00692 R00693 R00694;R00695 R00697 R00698 R00699 R01375 R01376 R01795 R03660;R06744 R07211 R08463 R08652 R08690 R09535 R09578 R09579;R10286 R10287 R10495 R10499 R10729 R11068 R11918 R12413;R12540 R12543
Hexacosanoic acid NIST,C21931,Hexacosanoic acid,NA,NA,NA,NA,NA,NA
L-glutamic acid,cpd:C00025,L-Glutamate;L-Glutamic acid;L-Glutaminic acid;Glutamate,C5H9NO4,"Arginine biosynthesis;Alanine, aspartate and glutamate metabolism;Arginine and proline metabolism;Carbapenem biosynthesis;Histidine metabolism;Taurine and hypotaurine metabolism;D-Amino acid metabolism;Glutathione metabolism;Neomycin, kanamycin and gentamicin biosynthesis;Glyoxylate and dicarboxylate metabolism;Butanoate metabolism;C5-Branched dibasic acid metabolism;Porphyrin metabolism;Nitrogen metabolism;Aminoacyl-tRNA biosynthesis;Biosynthesis of various other secondary metabolites;Biosynthesis of various antibiotics;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;ABC transporters;Two-component system;FoxO signaling pathway;Phospholipase D signaling pathway;Neuroactive ligand-receptor interaction;Ferroptosis;Gap junction;Circadian entrainment;Long-term potentiation;Synaptic vesicle cycle;Retrograde endocannabinoid signaling;Glutamatergic synapse;GABAergic synapse;Long-term depression;Taste transduction;Proximal tubule bicarbonate reclamation;Protein digestion and absorption;Amyotrophic lateral sclerosis;Huntington disease;Spinocerebellar ataxia;Pathways of neurodegeneration - multiple diseases;Cocaine addiction;Amphetamine addiction;Nicotine addiction;Alcoholism;Central carbon metabolism in cancer","Proline biosynthesis, glutamate => proline;GABA (gamma-Aminobutyrate) shunt;Ornithine biosynthesis, glutamate => ornithine;Histidine degradation, histidine => N-formiminoglutamate => glutamate;Glutathione biosynthesis, glutamate => glutathione;Heme biosynthesis, plants and bacteria, glutamate => heme;Photorespiration;Methylaspartate cycle;Ornithine biosynthesis, mediated by LysW, glutamate => ornithine;Arginine biosynthesis, glutamate => acetylcitrulline => arginine;Arginine succinyltransferase pathway, arginine => glutamate;Proline degradation, proline => glutamate",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00025  Glutamic acid (Glu); Hormones and transmitters;  Neurotransmitters;   Amino acids;    C00025  Glutamate;Risk category of Japanese OTC drugs [BR:br08312(D00007)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Glutamic acid;    D00007  Glutamic acid (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00007)]; Chemicals;  D00007  L-Glutamic acid,1.2.1.88;1.4.1.2;1.4.1.3;1.4.1.4;1.4.1.13;1.4.1.14;1.4.3.11;1.4.7.1;1.5.1.9;1.5.1.10;1.5.3.18;1.5.99.5;1.14.11.76;2.1.1.21;2.1.2.5;2.3.1.1;2.3.1.14;2.3.1.35;2.3.2.2;2.3.2.-;2.4.2.14;2.5.1.140;2.6.1.1;2.6.1.2;2.6.1.3;2.6.1.4;2.6.1.5;2.6.1.6;2.6.1.7;2.6.1.9;2.6.1.11;2.6.1.13;2.6.1.16;2.6.1.17;2.6.1.19;2.6.1.22;2.6.1.23;2.6.1.24;2.6.1.26;2.6.1.27;2.6.1.29;2.6.1.33;2.6.1.34;2.6.1.36;2.6.1.38;2.6.1.39;2.6.1.42;2.6.1.44;2.6.1.48;2.6.1.49;2.6.1.52;2.6.1.55;2.6.1.57;2.6.1.59;2.6.1.65;2.6.1.67;2.6.1.72;2.6.1.75;2.6.1.76;2.6.1.79;2.6.1.80;2.6.1.81;2.6.1.82;2.6.1.83;2.6.1.85;2.6.1.86;2.6.1.87;2.6.1.89;2.6.1.90;2.6.1.92;2.6.1.93;2.6.1.94;2.6.1.95;2.6.1.98;2.6.1.102;2.6.1.103;2.6.1.104;2.6.1.106;2.6.1.107;2.6.1.109;2.6.1.110;2.6.1.111;2.6.1.114;2.6.1.116;2.6.1.118;2.6.1.120;2.6.1.122;2.6.1.123;2.6.1.-;2.7.2.11;3.4.17.21;3.4.19.9;3.4.19.13;3.4.19.14;3.4.19.16;3.5.1.2;3.5.1.38;3.5.1.55;3.5.1.65;3.5.1.68;3.5.1.87;3.5.1.94;3.5.1.96;3.5.1.118;3.5.1.123;3.5.1.129;3.5.2.9;3.5.3.8;4.1.1.15;4.1.3.27;4.2.1.168;4.3.2.10;4.3.3.6;5.1.1.3;5.4.3.9;5.4.99.1;6.1.1.17;6.1.1.24;6.2.1.39;6.2.1.68;6.3.1.2;6.3.1.6;6.3.1.11;6.3.1.17;6.3.1.18;6.3.2.2;6.3.2.12;6.3.2.17;6.3.2.18;6.3.2.31;6.3.2.32;6.3.2.33;6.3.2.34;6.3.2.41;6.3.2.42;6.3.2.53;6.3.2.60;6.3.2.-;6.3.4.2;6.3.4.12;6.3.4.24;6.3.5.1;6.3.5.2;6.3.5.3;6.3.5.4;6.3.5.5;6.3.5.6;6.3.5.7;6.3.5.9;6.3.5.10;6.3.5.11;6.3.5.12;6.3.5.13;6.3.5.-,R00021 R00093 R00114 R00239 R00243 R00245 R00248 R00250;R00251 R00253 R00254 R00256 R00257 R00258 R00259 R00260;R00261 R00262 R00263 R00355 R00372 R00411 R00457 R00494;R00525 R00573 R00575 R00578 R00609 R00667 R00668 R00684;R00694 R00707 R00708 R00734 R00768 R00894 R00895 R00908;R00942 R00986 R01072 R01090 R01155 R01161 R01214 R01231;R01339 R01585 R01586 R01648 R01654 R01684 R01716 R01939;R01956 R02040 R02077 R02199 R02237 R02274 R02282 R02283;R02285 R02287 R02313 R02315 R02433 R02619 R02700 R02772;R02773 R02929 R02930 R03053 R03120 R03189 R03207 R03243;R03266 R03651 R03905 R03916 R03952 R03970 R03971 R04028;R04029 R04051 R04171 R04173 R04188 R04212 R04217 R04234;R04241 R04242 R04269 R04338 R04438 R04463 R04467 R04475;R04529 R04558 R04776 R05052 R05085 R05197 R05207 R05224;R05225 R05507 R05578 R05815 R06423 R06426 R06586 R06631;R06634 R06977 R07275 R07276 R07277 R07396 R07414 R07419;R07456 R07613 R07643 R07659 R08244 R08855 R08897 R08903;R08905 R08906 R08931 R08956 R09195 R09399 R09400 R09401;R09495 R09594 R09598 R09599 R09778 R09824 R09825 R09875;R10086 R10089 R10094 R10141 R10153 R10460 R10677 R10678;R10679 R10687 R10688 R10693 R10698 R10772 R10845 R10902;R10929 R10932 R10991 R10993 R11021 R11118 R11269 R11270;R11285 R11291 R11297 R11298 R11299 R11395 R11409 R11475;R11515 R11561 R11607 R11627 R11705 R11792 R11793 R11794;R11795 R11960 R11963 R12214 R12251 R12272 R12352 R12410;R12412 R12590 R12606 R12663 R12688 R12728 R12730 R12906;R12936 R12939 R13098 R13148
L-leucine,cpd:C00123,L-Leucine;2-Amino-4-methylvaleric acid;(2S)-alpha-2-Amino-4-methylvaleric acid;(2S)-alpha-Leucine,C6H13NO2,"Valine, leucine and isoleucine degradation;Valine, leucine and isoleucine biosynthesis;Glucosinolate biosynthesis;Aminoacyl-tRNA biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from histidine and purine;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;ABC transporters;mTOR signaling pathway;Protein digestion and absorption;Mineral absorption;Shigellosis;Central carbon metabolism in cancer","Leucine degradation, leucine => acetoacetate + acetyl-CoA",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00123  Leucine (Leu);Risk category of Japanese OTC drugs [BR:br08312(D00030)]; Third-class OTC drugs;  Inorganic and organic chemicals;   L-Leucine;    D00030  Leucine (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00030)]; Chemicals;  D00030  L-Leucine,1.4.1.9;1.14.13.-;2.3.1.66;2.6.1.6;2.6.1.42;2.6.1.67;3.5.1.64;5.4.3.7;6.1.1.4;6.3.2.47,R01088 R01089 R01090 R01091 R02552 R03657 R08411 R08664;R10944
L-serine,cpd:C00065,L-Serine;L-2-Amino-3-hydroxypropionic acid;L-3-Hydroxy-alanine;Serine,C3H7NO3,"Glycine, serine and threonine metabolism;Monobactam biosynthesis;Cysteine and methionine metabolism;Cyanoamino acid metabolism;D-Amino acid metabolism;Glycerophospholipid metabolism;Sphingolipid metabolism;Glyoxylate and dicarboxylate metabolism;Methane metabolism;Sulfur metabolism;Aminoacyl-tRNA biosynthesis;Biosynthesis of various other secondary metabolites;Biosynthesis of various antibiotics;Biosynthesis of plant secondary metabolites;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;Vancomycin resistance;ABC transporters;Sphingolipid signaling pathway;Protein digestion and absorption;Mineral absorption;Central carbon metabolism in cancer","Serine biosynthesis, glycerate-3P => serine;Cysteine biosynthesis, serine => cysteine;Methionine degradation;Ceramide biosynthesis;Cysteine biosynthesis, homocysteine + serine => cysteine;Formaldehyde assimilation, serine pathway;Photorespiration;Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A;Cycloserine biosynthesis, arginine/serine => cycloserine;Staphyloferrin B biosynthesis, L-serine => staphyloferrin B;Betaine degradation, bacteria, betaine => pyruvate",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00065  Serine (Ser);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00016)]; Chemicals;  D00016  L-Serine,1.1.1.276;1.1.1.387;1.4.1.7;2.1.2.1;2.3.1.30;2.3.1.50;2.6.1.45;2.6.1.51;2.7.1.80;2.7.1.225;2.7.1.226;2.7.8.4;2.7.8.8;2.7.8.29;2.7.8.38;2.8.1.4;3.1.3.3;3.1.4.13;4.1.1.-;4.2.1.20;4.2.1.22;4.2.1.50;4.2.1.122;4.3.1.17;4.3.1.19;5.1.1.10;5.1.1.18;6.1.1.11;6.2.1.72;6.3.2.14,R00220 R00581 R00582 R00584 R00585 R00586 R00588 R00589;R00590 R00674 R00891 R00945 R01281 R01289 R01290 R01800;R02378 R02563 R02722 R02817 R03662 R03923 R04942 R06126;R07376 R07377 R07644 R08218 R09099 R10255 R10441 R10880;R10984 R10985 R10986 R11667 R12342 R12344 R12757 R12779;R12781 R13249
Octacosanoic acid NIST,NA,NA,NA,NA,NA,NA,NA,NA
Tricosanoic acid NIST,NA,NA,NA,NA,NA,NA,NA,NA
Alanine,cpd:C00041,L-Alanine;L-2-Aminopropionic acid;L-alpha-Alanine,C3H7NO2,"Alanine, aspartate and glutamate metabolism;Cysteine and methionine metabolism;Taurine and hypotaurine metabolism;Selenocompound metabolism;D-Amino acid metabolism;Carbon fixation in photosynthetic organisms;Aminoacyl-tRNA biosynthesis;Biosynthesis of various other secondary metabolites;Biosynthesis of plant secondary metabolites;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Vancomycin resistance;ABC transporters;Sulfur relay system;Protein digestion and absorption;Mineral absorption;Central carbon metabolism in cancer","C4-dicarboxylic acid cycle, NAD - malic enzyme type;Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline",Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00041  Alanine (Ala);Risk category of Japanese OTC drugs [BR:br08312(D00012)]; Third-class OTC drugs;  Inorganic and organic chemicals;   L-Alanine;    D00012  Alanine (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00012)]; Chemicals;  D00012  L-Alanine,1.4.1.1;1.5.1.17;2.3.1.47;2.6.1.2;2.6.1.12;2.6.1.15;2.6.1.18;2.6.1.30;2.6.1.37;2.6.1.40;2.6.1.41;2.6.1.43;2.6.1.44;2.6.1.46;2.6.1.47;2.6.1.51;2.6.1.56;2.6.1.58;2.6.1.66;2.6.1.71;2.6.1.77;2.6.1.84;2.6.1.96;2.6.1.99;2.6.1.108;2.6.1.113;2.6.1.115;2.6.1.119;2.8.1.7;2.8.1.9;3.5.1.28;3.7.1.3;4.1.1.12;4.1.1.64;4.4.1.16;5.1.1.1;6.1.1.7;6.2.1.67;6.3.2.8;6.3.2.49;6.3.2.-,R00258 R00369 R00396 R00397 R00398 R00400 R00401 R00453;R00576 R00585 R00692 R00863 R00907 R00987 R01215 R01261;R01712 R02050 R02271 R02293 R02668 R02970 R03001 R03038;R03193 R03210 R03502 R03599 R03854 R03936 R04112 R04152;R04187 R05652 R07460 R08197 R08714 R08872 R09048 R09254;R10124 R10178 R10180 R10992 R11038 R11064 R11528 R11583;R12343 R12417 R12419 R12622 R12725 R12727
Ethanol,cpd:C00469,Ethanol;Ethyl alcohol;Methylcarbinol,C2H6O,Glycolysis / Gluconeogenesis;Pyruvate metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Inflammatory mediator regulation of TRP channels;Alcoholic liver disease;Alcoholism;Chemical carcinogenesis - reactive oxygen species,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00068)]; D DERMATOLOGICALS;  D08 ANTISEPTICS AND DISINFECTANTS;   D08A ANTISEPTICS AND DISINFECTANTS;    D08AX Other antiseptics and disinfectants;     D08AX08 Ethanol;      D00068  Alcohol (USP) &lt;JP/US&gt;; V VARIOUS;  V03 ALL OTHER THERAPEUTIC PRODUCTS;   V03A ALL OTHER THERAPEUTIC PRODUCTS;    V03AB Antidotes;     V03AB16 Ethanol;      D00068  Alcohol (USP) &lt;JP/US&gt;;    V03AZ Nerve depressants;     V03AZ01 Ethanol;      D00068  Alcohol (USP) &lt;JP/US&gt;;Therapeutic category of drugs in Japan [BR:br08301(D00068)]; 2  Agents affecting individual organs;  26  Epidermides;   261  Antimicrobial agents;    2615  Alcohols;     D00068  Alcohol (USP); Anhydrous ethanol (JP18); 4  Agents affecting cellular function;  42  Antineoplastics;   429  Miscellaneous;    4291  Other Antitumors;     D00068  Alcohol (USP); Anhydrous ethanol (JP18);Classification of Japanese OTC drugs [BR:br08313(D00068)]; Agents for integumentary system;  54 Disinfectants (incl. special bandages);   D00068  Alcohol (USP);Risk category of Japanese OTC drugs [BR:br08312(D00068)]; Second-class OTC drugs;  Inorganic and organic chemicals;   Ethanol;    D00068  Alcohol (USP); Third-class OTC drugs;  Inorganic and organic chemicals;   Ethanol;    D00068  Alcohol (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00068)]; Chemicals;  D00068  Anhydrous ethanol,1.1.1.1;1.1.1.2;1.1.1.71;1.1.2.7;1.1.2.8;1.1.5.5;1.1.99.36;2.3.1.152;2.3.1.268;3.1.1.67;3.1.1.113;3.5.1.75,R00746 R00754 R02359 R02682 R04410 R05198 R09127 R09479;R09552 R11957 R12515
Glucose,cpd:C00031,D-Glucose;Grape sugar;Dextrose;Glucose;D-Glucopyranose,C6H12O6,"Glycolysis / Gluconeogenesis;Pentose phosphate pathway;Galactose metabolism;Starch and sucrose metabolism;Amino sugar and nucleotide sugar metabolism;Streptomycin biosynthesis;Neomycin, kanamycin and gentamicin biosynthesis;Indole alkaloid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Two-component system;Phosphotransferase system (PTS);HIF-1 signaling pathway;FoxO signaling pathway;Meiosis - yeast;Efferocytosis;AMPK signaling pathway;Taste transduction;Insulin signaling pathway;Insulin secretion;Prolactin signaling pathway;Glucagon signaling pathway;Type II diabetes mellitus;Insulin resistance;Non-alcoholic fatty liver disease;AGE-RAGE signaling pathway in diabetic complications;Carbohydrate digestion and absorption;Bile secretion;Mineral absorption;Biofilm formation - Vibrio cholerae;Central carbon metabolism in cancer;Diabetic cardiomyopathy",NA,"Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Aldoses;    C00031  D-Glucose;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00009)]; B BLOOD AND BLOOD FORMING ORGANS;  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;   B05C IRRIGATING SOLUTIONS;    B05CX Other irrigating solutions;     B05CX01 Glucose;      D00009  Glucose (JP18) &lt;JP&gt;; V VARIOUS;  V04 DIAGNOSTIC AGENTS;   V04C OTHER DIAGNOSTIC AGENTS;    V04CA Tests for diabetes;     V04CA02 Glucose;      D00009  Glucose (JP18) &lt;JP&gt;;  V06 GENERAL NUTRIENTS;   V06D OTHER NUTRIENTS;    V06DC Carbohydrates;     V06DC01 Glucose;      D00009  Glucose (JP18) &lt;JP&gt;;Therapeutic category of drugs in Japan [BR:br08301(D00009)]; 3  Agents affecting metabolism;  32  Nutrients, tonics;   323  Saccharide preparations;    3231  Glucoses;     D00009  Glucose (JP18); Purified glucose (JP18);Risk category of Japanese OTC drugs [BR:br08312(D00009)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Glucose;    D00009  Glucose (JP18);Animal drugs in Japan [BR:br08331]; 96  Agents affecting metabolism;  964  Saccharide preparations and blood substitutes;   9641  Dextrose and preparations;    C00031  D-Glucose;Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00009)]; Chemicals;  D00009  Glucose;  D00009  Purified glucose;  D00009  Glucose injection",1.1.1.118;1.1.1.119;1.1.1.121;1.1.1.359;1.1.1.360;1.1.1.432;1.1.3.10;1.1.5.2;1.1.5.9;1.1.99.28;1.1.99.35;2.3.1.72;2.3.1.90;2.3.1.91;2.3.1.92;2.3.1.103;2.3.1.143;2.3.1.152;2.3.1.-;2.4.1.8;2.4.1.9;2.4.1.10;2.4.1.20;2.4.1.22;2.4.1.25;2.4.1.31;2.4.1.64;2.4.1.99;2.4.1.230;2.4.1.245;2.4.1.279;2.4.1.281;2.7.1.1;2.7.1.2;2.7.1.41;2.7.1.42;2.7.1.61;2.7.1.62;2.7.1.63;2.7.1.142;2.7.1.147;2.7.1.199;3.1.1.33;3.1.3.9;3.1.3.10;3.1.3.58;3.1.4.48;3.1.6.3;3.2.1.3;3.2.1.10;3.2.1.20;3.2.1.21;3.2.1.22;3.2.1.23;3.2.1.26;3.2.1.28;3.2.1.39;3.2.1.42;3.2.1.45;3.2.1.48;3.2.1.58;3.2.1.74;3.2.1.86;3.2.1.93;3.2.1.104;3.2.1.105;3.2.1.107;3.2.1.108;3.2.1.117;3.2.1.118;3.2.1.122;3.2.1.125;3.2.1.126;3.2.1.147;3.2.1.175;3.2.1.182;3.2.1.186;3.2.1.188;3.2.1.189;3.2.1.205;3.2.1.206;3.2.1.207;3.2.1.208;3.2.1.216;3.2.1.220;3.2.1.-;4.2.99.22;4.2.99.23,R00010 R00015 R00028 R00049 R00063 R00299 R00300 R00301;R00302 R00303 R00304 R00305 R00306 R00308 R00327 R00337;R00503 R00534 R00550 R00725 R00801 R00837 R00838 R00839;R00850 R00874 R00952 R00953 R00960 R01006 R01100 R01101;R01139 R01444 R01460 R01498 R01555 R01718 R01790 R01791;R02185 R02558 R02595 R02727 R02738 R02887 R02985 R03075;R03323 R03527 R03604 R03703 R03801 R03802 R03820 R04006;R04094 R04194 R04333 R04409 R04410 R04411 R04498 R04503;R04949 R04998 R05061 R05140 R05141 R05142 R05196 R05804;R05980 R05981 R06040 R06053 R06056 R06058 R06059 R06067;R06069 R06079 R06080 R06087 R06091 R06103 R06104 R06105;R06106 R06107 R06108 R06109 R06112 R06113 R06114 R06115;R06135 R06204 R06620 R07147 R07264 R08404 R08432 R08514;R08819 R08823 R08946 R09039 R09723 R09941 R09943 R10411;R10494 R10525 R10530 R10580 R10581 R11215 R11306 R11682;R11791 R11942 R12208 R12209 R12250 R12983 R12997 R13178;R13191
Isocaproate,cpd:C21399,Isocaproate;4-Methylpentanoate,C6H12O2,NA,NA,NA,2.8.3.24,R11462
1-Hexacosanol NIST,C08381,1-Hexacosanol,NA,NA,NA,NA,NA,NA
3-3-hydroxyphenylpropionic acid,C11457,3-(3-Hydroxyphenyl)propanoic acid,NA,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,NA,NA
3-4-hydroxyphenylpropionic acid,C01744,3-(4-Hydroxyphenyl)propionic acid,NA,Degradation of flavonoids;Metabolic pathways,NA,NA,NA,NA
3-hydroxybutyric acid,NA,3-hydroxybutyric acid,NA,NA,NA,NA,NA,NA
4-guanidinobutyric acid,cpd:C01035,4-Guanidinobutanoate;4-Guanidinobutyric acid,C5H11N3O2,Arginine and proline metabolism;Metabolic pathways,NA,NA,1.2.1.54;2.1.4.1;3.5.1.4;3.5.3.7,R01989 R01990 R03177 R03180
5-Trimethylsilyloxy-n-valeric acid NIST,NA,5-Trimethylsilyloxy-n-valeric acid,NA,NA,NA,NA,NA,NA
benzoic acid,cpd:C00180,Benzoate;Benzoic acid;Benzenecarboxylic acid;Phenylformic acid;Dracylic acid,C7H6O2,Benzoate degradation;Dioxin degradation;Toluene degradation;Aminobenzoate degradation;Biosynthesis of various alkaloids;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Toluene degradation, toluene => benzoate;Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate;Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",Therapeutic category of drugs in Japan [BR:br08301(D00038)]; 7  Agents not mainly for therapeutic purpose;  73  Public health agents;   731  Antiseptics;    7319  Others;     D00038  Benzoic acid (JP18/USP);Risk category of Japanese OTC drugs [BR:br08312(D00038)]; Designated second-class OTC drugs;  Inorganic and organic chemicals;   Benzoic acid;    D00038  Benzoic acid (JP18/USP); Second-class OTC drugs;  Inorganic and organic chemicals;   Benzoic acid;    D00038  Benzoic acid (JP18/USP); Third-class OTC drugs;  Inorganic and organic chemicals;   Benzoic acid;    D00038  Benzoic acid (JP18/USP);Animal drugs in Japan [BR:br08331]; 99  Agents for not mainly purpose of therapeutic;  992  Amphoteric soap and preparations;   9929  Other agents for disinfections;    C00180  Benzoate;Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00038)]; Chemicals;  D00038  Benzoic acid,1.2.1.7;1.2.1.28;1.14.12.10;1.14.13.-;1.14.14.92;2.1.1.273;3.1.1.1;3.1.1.84;3.5.1.4;3.5.1.32;3.5.1.40;3.5.5.1;3.6.1.7;3.6.1.20;3.7.1.8;6.2.1.25,R01295 R01419 R01420 R01421 R01422 R01423 R01424 R01425;R01426 R01427 R02606 R05590 R05591 R05621 R05622 R06727;R06728 R07188 R07835 R08838 R09088 R10447
caprylic acid,cpd:C06423,Octanoic acid;Caprylic acid;Octylic acid;Octanoate,C8H16O2,Fatty acid biosynthesis;Lipoic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from terpenoid and polyketide;Metabolic pathways;Biosynthesis of cofactors,NA,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C06423  Caprylate; Octanoate; Lipids;  Fatty acids;   Saturated fatty acids;    C06423  Caprylic acid (8:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C06423  Octanoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Saturated fatty acids;    C06423  Octanoic acid,3.1.2.21;6.3.1.20,R08157 R08509 R12429
DL-3-aminoisobutyric acid,NA,NA,NA,NA,NA,NA,NA,NA
L-Aspartic acid NIST,C00049,L-Aspartic acid,NA,"Arginine biosynthesis;Alanine, aspartate and glutamate metabolism;Glycine, serine and threonine metabolism;Monobactam biosynthesis;Cysteine and methionine metabolism;Lysine biosynthesis;Histidine metabolism;beta-Alanine metabolism;Cyanoamino acid metabolism;D-Amino acid metabolism;Carbon fixation in photosynthetic organisms;Nicotinate and nicotinamide metabolism;Pantothenate and CoA biosynthesis;Aminoacyl-tRNA biosynthesis;Biosynthesis of various other secondary metabolites; Including: Ditryptophenaline biosynthesis, Fumiquinazoline D biosynthesis, Paerucumarin biosynthesis, Staphyloferrin B biosynthesis, Cyclooctatin biosynthesis, Lovastatin biosynthesis, Grixazone biosynthesis, Staphyloferrin A biosynthesis, Ethynylserine biosynthesis, Aerobactin biosynthesis;Biosynthesis of various antibiotics; Including: Kanosamine biosynthesis, Aurachin biosynthesis, Bacilysin biosynthesis, Puromycin biosynthesis, Dapdiamides biosynthesis, Fosfomycin biosynthesis, Cremeomycin biosynthesis, Fumagillin biosynthesis, Pentalenolactone biosynthesis, Terpentecin biosynthesis, Roseoflavin biosynthesis, Cycloserine biosynthesis;Biosynthesis of various plant secondary metabolites; Including: Crocin biosynthesis, Ginsenoside biosynthesis, Saponin adjuvant biosynthesis, Cannabidiol biosynthesis, Mugineic acid biosynthesis, Pentagalloylglucose biosynthesis, Benzoxazinoid biosynthesis, Gramine biosynthesis, Coumarin biosynthesis, Furanocoumarin biosynthesis, Hordatine biosynthesis, Podophyllotoxin biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;ABC transporters;Two-component system;Bacterial chemotaxis;Neuroactive ligand-receptor interaction;Protein digestion and absorption;Central carbon metabolism in cancer",NA,NA,NA,NA
L-glutamic acid dehydrated,NA,NA,NA,NA,NA,NA,NA,NA
L-threonineM,NA,NA,NA,NA,NA,NA,NA,NA
methylmalonic acid,cpd:C02170,Methylmalonate;Methylmalonic acid,C4H6O4,"Pyrimidine metabolism;Valine, leucine and isoleucine degradation;Propanoate metabolism;Metabolic pathways",NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C02170  Methylmalonic acid,1.2.1.3;1.2.3.1;3.1.2.17;3.5.1.95;3.5.2.1;6.2.1.-,R02764 R03383 R03869 R03870 R03871 R03872 R10778
myo-inositol,cpd:C00137,myo-Inositol;D-myo-Inositol;1D-myo-Inositol;L-myo-Inositol;1L-myo-Inositol;meso-Inositol;Inositol;Dambose;Cyclohexitol;Meat sugar;Bios I,C6H12O6,Galactose metabolism;Ascorbate and aldarate metabolism;Streptomycin biosynthesis;Inositol phosphate metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of nucleotide sugars;ABC transporters;Phosphatidylinositol signaling system,"Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol",Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar alcohols;    C00137  myo-Inositol;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08079)]; A ALIMENTARY TRACT AND METABOLISM;  A11 VITAMINS;   A11H OTHER PLAIN VITAMIN PREPARATIONS;    A11HA Other plain vitamin preparations;     A11HA07 Inositol;      D08079  Inositol (NF);Risk category of Japanese OTC drugs [BR:br08312(D08079)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Inositol;    D08079  Inositol (NF),1.1.1.18;1.13.99.1;2.1.1.39;2.1.1.40;2.1.1.129;2.3.1.72;2.4.1.67;2.4.1.82;2.4.1.123;2.7.1.64;2.7.8.11;3.1.3.25;3.1.4.44;3.2.1.22,R01183 R01184 R01185 R01186 R01187 R01188 R01189 R01190;R01192 R01193 R01194 R01802 R02411 R03418 R04333 R06042;R06071 R06093 R06214 R07279 R07343
phenylethylamine,cpd:C05332,Phenethylamine;2-Phenylethylamine;beta-Phenylethylamine;Phenylethylamine,C8H11N,Phenylalanine metabolism;Metabolic pathways,NA,Compounds with biological roles [BR:br08001]; Peptides;  Amines;   Biogenic amines;    C05332  Phenethylamine,1.4.3.4;1.4.3.21;1.4.9.2;3.5.1.85;4.1.1.28;4.1.1.53,R00699 R02612 R02613 R07301
pimelic acid,cpd:C02656,Pimelate;Pimelic acid;Heptanedioic acid;6-Carboxyhexanoate,C7H12O4,Biotin metabolism;Metabolic pathways;Biosynthesis of cofactors,"Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Dicarboxylic acids;    C02656  Pimelate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C02656  Heptanedioic acid,6.2.1.14,R03209
p-Toluic acid NIST,C01454,4-Methylbenzoic acid,NA,Xylene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,NA,NA
putrescine,cpd:C00134,"Putrescine;1,4-Butanediamine;1,4-Diaminobutane;Tetramethylenediamine;Butane-1,4-diamine",C4H12N2,"Arginine and proline metabolism;D-Amino acid metabolism;Glutathione metabolism;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Efferocytosis;Protein digestion and absorption","Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine;Polyamine biosynthesis, arginine => ornithine => putrescine;GABA biosynthesis, eukaryotes, putrescine => GABA;GABA biosynthesis, prokaryotes, putrescine => GABA",Compounds with biological roles [BR:br08001]; Peptides;  Amines;   Biogenic amines;    C00134  Putrescine,1.4.3.10;1.4.3.22;1.5.1.43;1.5.3.13;1.5.3.17;2.1.1.53;2.1.3.6;2.3.1.57;2.3.1.138;2.3.1.-;2.5.1.16;2.5.1.44;2.5.1.45;2.6.1.29;2.6.1.82;2.6.1.113;3.5.1.53;3.5.1.62;3.5.3.11;4.1.1.17;4.1.1.116;6.3.1.11,R00018 R00670 R01151 R01152 R01153 R01154 R01155 R01156;R01157 R01399 R01919 R01920 R01944 R07414 R08714 R09074;R09077 R09079 R09256 R09257 R12304
1-Butanol,cpd:C06142,1-Butanol;n-Butanol;Butan-1-ol,C4H10O,Butanoate metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA05 Fatty alcohols;   C06142  1-Butanol,1.1.1.-;1.1.2.9;1.1.5.11;1.14.13.230,R03544 R03545 R11343 R11344 R11448
"3,7-Dimethyluric acid",cpd:C16360,"3,7-Dimethyluric acid",C7H8N4O3,Caffeine metabolism,NA,"Phytochemical compounds [BR:br08003]; Alkaloids;  Others;   Purine alkaloids;    C16360  3,7-Dimethyluric acid",1.17.3.2,R07978
Acetate,cpd:C00033,Acetate;Acetic acid;Ethanoic acid,C2H4O2,Glycolysis / Gluconeogenesis;Taurine and hypotaurine metabolism;Phosphonate and phosphinate metabolism;Glycosaminoglycan biosynthesis - heparan sulfate / heparin;Pyruvate metabolism;Glyoxylate and dicarboxylate metabolism;C5-Branched dibasic acid metabolism;Methane metabolism;Carbon fixation pathways in prokaryotes;Zeatin biosynthesis;Sulfur metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Degradation of aromatic compounds;Cholinergic synapse;Alcoholic liver disease;Carbohydrate digestion and absorption;Protein digestion and absorption,"Methanogenesis, acetate => methane;Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate","Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C00033  Acetate; Ethanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C00033  Acetic acid;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00010)]; G GENITO URINARY SYSTEM AND SEX HORMONES;  G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;   G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;    G01AD Organic acids;     G01AD02 Acetic acid;      D00010  Acetic acid, glacial (USP) &lt;JP/US&gt;; S SENSORY ORGANS;  S02 OTOLOGICALS;   S02A ANTIINFECTIVES;    S02AA Antiinfectives;     S02AA10 Acetic acid;      D00010  Acetic acid, glacial (USP) &lt;JP/US&gt;;USP drug classification [BR:br08302(D00010)]; Antibacterials;  Antibacterials, Other;   Acetic Acid;    D00010  Acetic acid, glacial (USP); Dermatological Agents;  Topical Anti-infectives;   Antibacterials, dermatological;    Acetic Acid;     D00010  Acetic acid, glacial (USP);Therapeutic category of drugs in Japan [BR:br08301(D00010)]; 2  Agents affecting individual organs;  26  Epidermides;   264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;    2649  Others;     D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18);   266  Emollients;    2661  Organic acids;     D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18); 7  Agents not mainly for therapeutic purpose;  71  Dispensing medicines;   714  Flavorings, deodorants, coloring agents;    7149  Others;     D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18);   719  Miscellaneous;    7190  Miscellaneous;     D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18);Risk category of Japanese OTC drugs [BR:br08312(D00010)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Acetic acid;    D00010  Acetic acid, glacial (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00010)]; Chemicals;  D00010  Acetic acid;  D00010  Glacial acetic acid",1.1.1.318;1.1.1.319;1.2.1.3;1.2.1.4;1.2.1.5;1.2.1.-;1.2.5.1;1.2.5.2;1.2.99.6;1.13.11.50;1.13.12.4;1.14.13.54;1.14.14.32;2.1.1.152;2.3.1.187;2.5.1.47;2.5.1.48;2.5.1.49;2.5.1.50;2.5.1.51;2.5.1.52;2.5.1.53;2.5.1.65;2.5.1.118;2.5.1.119;2.5.1.134;2.5.1.144;2.6.99.3;2.7.2.1;2.7.2.12;2.7.2.15;2.8.3.1;2.8.3.3;2.8.3.8;2.8.3.10;2.8.3.11;2.8.3.12;2.8.3.14;2.8.3.18;2.8.3.19;2.8.3.-;3.1.1.2;3.1.1.6;3.1.1.7;3.1.1.8;3.1.1.33;3.1.1.41;3.1.1.47;3.1.1.53;3.1.1.54;3.1.1.55;3.1.1.56;3.1.1.58;3.1.1.66;3.1.1.71;3.1.1.80;3.1.1.94;3.1.1.105;3.1.1.106;3.1.1.112;3.1.1.113;3.1.1.114;3.1.2.1;3.1.2.16;3.5.1.4;3.5.1.14;3.5.1.15;3.5.1.16;3.5.1.17;3.5.1.21;3.5.1.25;3.5.1.29;3.5.1.33;3.5.1.41;3.5.1.47;3.5.1.48;3.5.1.51;3.5.1.62;3.5.1.63;3.5.1.66;3.5.1.76;3.5.1.85;3.5.1.89;3.5.1.103;3.5.1.104;3.5.1.105;3.5.1.108;3.5.1.112;3.5.1.113;3.5.1.114;3.5.1.125;3.5.1.135;3.5.1.136;3.5.1.-;3.6.1.7;3.6.1.20;3.7.1.1;3.7.1.6;3.7.1.24;3.7.1.25;3.11.1.2;4.1.1.88;4.1.3.4;4.1.3.6;4.1.3.22;4.1.3.26;4.2.99.24;6.2.1.1;6.2.1.13;6.2.1.22;6.2.1.35,R00227 R00229 R00235 R00315 R00316 R00317 R00318 R00319;R00320 R00321 R00322 R00324 R00325 R00326 R00327 R00338;R00362 R00393 R00458 R00488 R00628 R00651 R00669 R00710;R00711 R00743 R00897 R00909 R00928 R01019 R01026 R01156;R01179 R01200 R01241 R01287 R01308 R01323 R01359 R01426;R01649 R01810 R01987 R02026 R02059 R02276 R02333 R02733;R02942 R02955 R03062 R03131 R03132 R03133 R03134 R03145;R03153 R03217 R03482 R03601 R03884 R04000 R04043 R04056;R04057 R04091 R04141 R04146 R04174 R04397 R04449 R04450;R04452 R04490 R04525 R04587 R04727 R04769 R04859 R04945;R05138 R05168 R05219 R05336 R05508 R05509 R05677 R05880;R05917 R06241 R06893 R07183 R07300 R07301 R07342 R07513;R07832 R08090 R08206 R08517 R08518 R08600 R08601 R08874;R08876 R08895 R08901 R08944 R09107 R09475 R09483 R09651;R09721 R09801 R09931 R10248 R10249 R10289 R10305 R10343;R10398 R10401 R10461 R10553 R10600 R10614 R10705 R10839;R10840 R11116 R11283 R11693 R11694 R11889 R11903 R12347;R12390 R12391 R12392 R12515 R12516 R12635 R12671 R12926;R13046 R13218
Acetone,cpd:C00207,Acetone;Dimethyl ketone;2-Propanone;Propan-2-one,C3H6O,Butanoate metabolism;Metabolic pathways,"Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone",Lipids [BR:br08002]; FA  Fatty acyls;  FA12 Oxygenated hydrocarbons;   C00207  Propan-2-one;Drug groups [BR:br08330(D02311)]; Metabolizing enzyme substrate;  DG02855  CYP2E1 substrate;   D02311  Acetone;Drug metabolizing enzymes and transporters [br08309.html(D02311)]; Drug metabolizing enzymes;  D02311,1.1.1.80;1.1.1.-;1.14.13.226;1.14.14.141;1.14.14.148;1.14.15.-;2.6.3.1;4.1.1.4;4.1.2.46;4.1.2.47;4.1.99.16;4.2.3.22;6.4.1.6,R01366 R01550 R01553 R03796 R05564 R05568 R05735 R08207;R08543 R09002 R09487 R10703 R10704
Butyrate,cpd:C00246,Butanoic acid;Butanoate;Butyrate;Butyric acid,C4H8O2,Butanoate metabolism;Metabolic pathways;Carbohydrate digestion and absorption;Protein digestion and absorption,NA,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C00246  Butyrate; Butanoate; Lipids;  Fatty acids;   Saturated fatty acids;    C00246  Butyric acid (4:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C00246  Butanoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Saturated fatty acids;    C00246  Butyric acid,1.3.1.31;2.7.2.7;2.8.3.8;2.8.3.9;3.1.1.51;3.6.1.20;3.7.1.7;6.2.1.2,R01176 R01179 R01365 R01688 R01689 R01690 R03781 R04119
Formate,cpd:C00058,Formate;Methanoic acid;Formic acid,CH2O2,Phosphonate and phosphinate metabolism;Pyruvate metabolism;Chloroalkane and chloroalkene degradation;Glyoxylate and dicarboxylate metabolism;Methane metabolism;Carbon fixation pathways in prokaryotes;Nitrogen metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Degradation of aromatic compounds,Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway),Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C00058  Formate; Methanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C00058  Formic acid,1.1.1.306;1.1.98.6;1.2.1.46;1.2.2.1;1.2.7.12;1.2.98.1;1.8.98.6;1.13.11.41;1.13.11.53;1.13.11.54;1.13.11.72;1.13.11.81;1.13.11.89;1.14.12.11;1.14.13.-;1.14.14.14;1.14.14.154;1.14.15.36;1.14.99.21;1.17.1.9;1.17.1.10;1.17.1.11;1.17.2.3;1.17.5.3;1.17.98.3;1.17.98.4;1.17.98.-;2.3.1.54;2.7.2.6;2.8.3.16;3.1.2.10;3.1.2.12;3.5.1.8;3.5.1.9;3.5.1.10;3.5.1.15;3.5.1.31;3.5.1.49;3.5.1.56;3.5.1.68;3.5.1.88;3.5.1.91;3.5.1.102;3.5.1.106;3.5.1.-;3.5.4.16;3.5.4.25;3.5.4.39;3.5.5.-;3.7.1.9;3.7.1.-;4.1.1.2;4.1.2.36;4.1.2.44;4.1.3.-;4.1.99.5;4.1.99.12;4.1.99.17;4.1.99.23;6.3.1.21;6.3.4.3;6.3.4.17;6.3.4.23,R00134 R00152 R00212 R00424 R00425 R00518 R00519 R00521;R00522 R00524 R00525 R00526 R00527 R00604 R00614 R00653;R00753 R00943 R00944 R00988 R01305 R01959 R02238 R02351;R02509 R02604 R03087 R03146 R03204 R03215 R03472 R03728;R03907 R04268 R04283 R04488 R04911 R05046 R05296 R05635;R05640 R05731 R05865 R06940 R06974 R06975 R06987 R07281;R07290 R07303 R07363 R07364 R07662 R07983 R08060 R08451;R08864 R09094 R09126 R09145 R09152 R09185 R09374 R09481;R09494 R09556 R10301 R10348 R10356 R10376 R10511 R10515;R10797 R11037 R11313 R11592 R11633 R11634 R11635 R11636;R11818 R11919 R11944 R12118 R12121 R12317 R12322 R12323;R12451 R12754
Glycolate,cpd:C00160,Glycolate;Glycolic acid;Hydroxyacetic acid,C2H4O3,Chlorocyclohexane and chlorobenzene degradation;Chloroalkane and chloroalkene degradation;Glyoxylate and dicarboxylate metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism,Photorespiration,NA,1.1.1.26;1.1.1.29;1.1.1.79;1.1.3.15;1.1.99.14;1.2.1.21;3.1.3.18;3.7.1.28;3.7.1.-;3.8.1.2;3.8.1.3;4.2.99.12,R00465 R00475 R00476 R00717 R01333 R01334 R01335 R01336;R02336 R02857 R05287 R12802
Isopropanol,cpd:C01845,Propan-2-ol;2-Propanol;Isopropanol;Isopropyl alcohol,C3H8O,Butanoate metabolism;Metabolic pathways,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00137)]; D DERMATOLOGICALS;  D08 ANTISEPTICS AND DISINFECTANTS;   D08A ANTISEPTICS AND DISINFECTANTS;    D08AX Other antiseptics and disinfectants;     D08AX05 Isopropanol;      D00137  Isopropyl alcohol (USP) &lt;JP&gt;;Therapeutic category of drugs in Japan [BR:br08301(D00137)]; 2  Agents affecting individual organs;  26  Epidermides;   261  Antimicrobial agents;    2615  Alcohols;     D00137  Isopropyl alcohol (USP); Isopropanol (JP18);Classification of Japanese OTC drugs [BR:br08313(D00137)]; Agents for integumentary system;  54 Disinfectants (incl. special bandages);   D00137  Isopropyl alcohol (USP);Risk category of Japanese OTC drugs [BR:br08312(D00137)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Isopropanol;    D00137  Isopropyl alcohol (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00137)]; Chemicals;  D00137  Isopropanol,1.1.1.80;1.1.1.-;1.14.13.227,R01550 R10702 R10703
Isovalerate,cpd:C08262,3-Methylbutanoic acid;Isovaleric acid;Isovalerate,C5H10O2,Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of secondary metabolites;Protein digestion and absorption,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0102 Branched fatty acids;    C08262  3-Methylbutanoic acid,NA,R08411 R08412
Lactate,cpd:C01432,Lactate;Lactic acid;2-Hydroxypropanoic acid;2-Hydroxypropionic acid,C3H6O3,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00111)]; G GENITO URINARY SYSTEM AND SEX HORMONES;  G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;   G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;    G01AD Organic acids;     G01AD01 Lactic acid;      D00111  Lactic acid (JP18/USP) &lt;JP&gt;;Therapeutic category of drugs in Japan [BR:br08301(D00111)]; 7  Agents not mainly for therapeutic purpose;  71  Dispensing medicines;   714  Flavorings, deodorants, coloring agents;    7149  Others;     D00111  Lactic acid (JP18/USP);Risk category of Japanese OTC drugs [BR:br08312(D00111)]; Third-class OTC drugs;  Inorganic and organic chemicals;   Lactic acid;    D00111  Lactic acid (JP18/USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00111)]; Chemicals;  D00111  Lactic acid",1.1.1.436;3.5.1.124,R11562 R11563 R11564 R11676
Methanol,cpd:C00132,Methanol;Methyl alcohol;CH3OH,CH4O,Butanoate metabolism;Methane metabolism;Indole alkaloid biosynthesis;Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Degradation of aromatic compounds,"Methane oxidation, methanotroph, methane => formaldehyde;Methanogenesis, methanol => methane",NA,1.1.1.244;1.1.2.7;1.1.2.10;1.1.3.13;1.1.99.37;1.2.98.1;1.11.1.6;1.11.1.7;1.11.1.21;1.13.11.8;1.13.11.-;1.14.13.25;1.14.14.117;1.14.18.3;2.1.1.90;2.1.1.246;2.3.1.152;2.3.1.232;3.1.1.11;3.1.1.44;3.1.1.59;3.1.1.61;3.1.1.78;3.1.1.82;3.1.1.85;3.1.1.95;3.1.1.97;3.1.1.100;3.1.1.114;3.1.1.122;3.1.1.-;3.1.6.16;3.3.2.14,R00602 R00605 R00608 R00614 R01142 R01143 R01144 R01145;R01146 R02362 R02624 R03551 R04280 R04384 R04409 R04608;R05825 R06250 R06685 R06729 R08149 R08150 R08974 R08975;R09061 R09098 R09273 R09274 R09337 R09518 R09553 R09725;R09846 R10319 R10320 R10545 R10681 R10705 R10983 R11166;R11189 R13238 R13239
Phenol,cpd:C00146,Phenol;Benzenol;Hydroxybenzene;Phenic acid;Phenylic acid,C6H6O,Tyrosine metabolism;Chlorocyclohexane and chlorobenzene degradation;Benzoate degradation;Aminobenzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Protein digestion and absorption;Chemical carcinogenesis - reactive oxygen species,"Benzene degradation, benzene => catechol","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00033)]; C CARDIOVASCULAR SYSTEM;  C05 VASOPROTECTIVES;   C05B ANTIVARICOSE THERAPY;    C05BB Sclerosing agents for local injection;     C05BB05 Phenol;      D00033  Phenol (JP18/USP) &lt;JP&gt;; D DERMATOLOGICALS;  D08 ANTISEPTICS AND DISINFECTANTS;   D08A ANTISEPTICS AND DISINFECTANTS;    D08AE Phenol and derivatives;     D08AE03 Phenol;      D00033  Phenol (JP18/USP) &lt;JP&gt;; N NERVOUS SYSTEM;  N01 ANESTHETICS;   N01B ANESTHETICS, LOCAL;    N01BX Other local anesthetics;     N01BX03 Phenol;      D00033  Phenol (JP18/USP) &lt;JP&gt;; R RESPIRATORY SYSTEM;  R02 THROAT PREPARATIONS;   R02A THROAT PREPARATIONS;    R02AA Antiseptics;     R02AA19 Phenol;      D00033  Phenol (JP18/USP) &lt;JP&gt;;Therapeutic category of drugs in Japan [BR:br08301(D00033)]; 2  Agents affecting individual organs;  25  Urogenital and anal organ agents;   255  Hemorrhoidal preparations;    2559  Others;     D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18);  26  Epidermides;   261  Antimicrobial agents;    2619  Others;     D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18);  27  Dental preparations;   273  Analgesics and sedatives;    2730  Analgesics and sedatives;     D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18); 7  Agents not mainly for therapeutic purpose;  73  Public health agents;   732  Germicides and disinfectants;    7322  Phenols and chlorophenols;     D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18);Classification of Japanese OTC drugs [BR:br08313(D00033)]; Agents for otolaryngologic use;  71 Ear drops;   D00033  Phenol (JP18/USP); Agents for dental and stomatological use;  75 Toothache and pyorrhea remedies;   D00033  Phenol (JP18/USP);Risk category of Japanese OTC drugs [BR:br08312(D00033)]; Second-class OTC drugs;  Inorganic and organic chemicals;   Phenol;    D00033  Phenol (JP18/USP);Animal drugs in Japan [BR:br08331]; 95  Agents for external use;  951  Antimicrobials for dermatologic use;   9519  Other antimicrobials for dermatologic use;    C00146  Phenol;Drug groups [BR:br08330(D00033)]; Neuropsychiatric agent;  DG02030  Anesthetics;   DG01675  Local anesthetic;    DG00301  Phenol;     D00033  Phenol;Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00033)]; Chemicals;  D00033  Phenol;  D00033  Liquefied phenol;  D00033  Phenol for disinfection",1.14.13.7;1.14.13.244;1.14.14.20;1.14.-.-;2.1.1.25;2.4.2.55;2.7.1.238;3.1.1.2;4.1.1.61;4.1.1.91;4.1.99.2,R00728 R00815 R01238 R01239 R01241 R05625 R07697 R09539;R10042 R10043 R10608 R11653 R12759
Phenylacetate,cpd:C07086,Phenylacetic acid;Benzylformic acid;Phenylacetate;Benzeneacetic acid,C8H8O2,Phenylalanine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments,"Phenylacetate degradation, phenylaxetate => acetyl-CoA/succinyl-CoA",Prodrugs [br08324.html]; C07086;Narcotics and psychotropics in Japan [br08308.html]; Stimulants by Control Act Article 2 Appended Table and Cabinet Order;  C07086,1.2.1.5;1.2.1.39;1.14.14.54;3.1.2.-;3.5.1.4;3.5.1.11;3.5.5.1;4.1.1.119;6.2.1.30,R02536 R02537 R02539 R02540 R04103 R05487 R06790 R06791;R07855 R09840 R12504
Propionate,cpd:C00163,Propanoate;Propionate;Propanoic acid;Propionic acid,C3H6O2,Propanoate metabolism;Ethylbenzene degradation;Nicotinate and nicotinamide metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Carbohydrate digestion and absorption;Protein digestion and absorption,NA,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C00163  Propionate; Propanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C00163  Propanoic acid,1.3.1.125;2.7.2.1;2.7.2.15;2.8.3.1;2.8.3.27;3.7.1.-;4.1.3.32;6.2.1.1;6.2.1.13;6.2.1.17,R00920 R00925 R00928 R01353 R01354 R01355 R01449 R05366;R11773 R13136
Propyl alcohol,cpd:C05979,Propane-1-ol;Propanol;1-Propanol;Propan-1-ol;Propyl alcohol;1-Hydroxypropane;Ethylcarbinol;n-Propanol;n-Propyl alcohol;Optal;Osmosol extra;UN 1274,C3H8O,Propanoate metabolism;Metabolic pathways,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA05 Fatty alcohols;   C05979  1-Propanol;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; D DERMATOLOGICALS;  D08 ANTISEPTICS AND DISINFECTANTS;   D08A ANTISEPTICS AND DISINFECTANTS;    D08AX Other antiseptics and disinfectants;     D08AX03 Propanol;      C05979  Propane-1-ol,1.1.1.202;2.3.1.152,R02377 R05061
Propylene glycol,cpd:C00583,"Propane-1,2-diol;1,2-Propanediol;Propylene glycol",C3H8O2,Propanoate metabolism;Metabolic pathways,NA,Therapeutic category of drugs in Japan [BR:br08301(D00078)]; 7  Agents not mainly for therapeutic purpose;  71  Dispensing medicines;   713  Solvents;    7139  Others;     D00078  Propylene glycol (JP18/USP);Animal drugs in Japan [BR:br08331]; 96  Agents affecting metabolism;  964  Saccharide preparations and blood substitutes;   9646  Propylene glycol and preparations;    C00583  Propylene glycol;Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00078)]; Chemicals;  D00078  Propylene glycol,1.1.1.6;1.1.1.21;1.1.1.55;1.1.1.77;4.2.1.28,R02257 R02259 R02376 R02577 R10717
Pyruvate,cpd:C00022,Pyruvate;Pyruvic acid;2-Oxopropanoate;2-Oxopropanoic acid;Pyroracemic acid,C3H4O3,"Glycolysis / Gluconeogenesis;Citrate cycle (TCA cycle);Pentose phosphate pathway;Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Alanine, aspartate and glutamate metabolism;Glycine, serine and threonine metabolism;Monobactam biosynthesis;Cysteine and methionine metabolism;Valine, leucine and isoleucine biosynthesis;Arginine and proline metabolism;Tyrosine metabolism;Phenylalanine metabolism;Benzoate degradation;Taurine and hypotaurine metabolism;Phosphonate and phosphinate metabolism;D-Amino acid metabolism;Pyruvate metabolism;Dioxin degradation;Xylene degradation;Glyoxylate and dicarboxylate metabolism;Butanoate metabolism;C5-Branched dibasic acid metabolism;Methane metabolism;Carbon fixation in photosynthetic organisms;Carbon fixation pathways in prokaryotes;Thiamine metabolism;Nicotinate and nicotinamide metabolism;Pantothenate and CoA biosynthesis;Lipoic acid metabolism;Terpenoid backbone biosynthesis;Biosynthesis of various other secondary metabolites;Biosynthesis of various antibiotics;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of cofactors;Vancomycin resistance;Phosphotransferase system (PTS);HIF-1 signaling pathway;AMPK signaling pathway;Insulin secretion;Glucagon signaling pathway;Type II diabetes mellitus;Insulin resistance;Central carbon metabolism in cancer;Diabetic cardiomyopathy","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate;Glycolysis, core module involving three-carbon compounds;Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate;Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine;D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P;C5 isoprenoid biosynthesis, non-mevalonate pathway;CAM (Crassulacean acid metabolism), light;C4-dicarboxylic acid cycle, NAD - malic enzyme type;C4-dicarboxylic acid cycle, NADP - malic enzyme type;Reductive citrate cycle (Arnon-Buchanan cycle);Pyruvate oxidation, pyruvate => acetyl-CoA;Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P;Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate;Dicarboxylate-hydroxybutyrate cycle;3-Hydroxypropionate bi-cycle;Isoleucine biosynthesis, pyruvate => 2-oxobutanoate;Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA;Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate;D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P;Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P;Betaine degradation, bacteria, betaine => pyruvate",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   2-Oxocarboxylic acids;    C00022  Pyruvate; 2-Oxopropanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C00022  2-Oxopropanoic acid,1.1.1.27;1.1.1.28;1.1.1.38;1.1.1.39;1.1.1.40;1.1.1.83;1.1.1.436;1.1.2.3;1.1.2.4;1.1.2.5;1.1.3.2;1.1.5.12;1.1.99.6;1.1.99.7;1.1.99.40;1.2.1.22;1.2.1.23;1.2.1.49;1.2.1.51;1.2.1.104;1.2.3.3;1.2.3.6;1.2.3.15;1.2.4.1;1.2.5.1;1.2.7.1;1.2.7.11;1.2.7.-;1.4.1.1;1.4.1.17;1.4.3.3;1.4.3.19;1.5.1.11;1.5.1.16;1.5.1.17;1.5.1.22;1.5.1.23;1.5.1.24;1.5.1.26;1.5.1.28;1.5.1.52;1.14.11.43;1.14.11.44;2.1.3.1;2.2.1.6;2.2.1.7;2.2.1.12;2.3.1.54;2.3.3.21;2.6.1.2;2.6.1.12;2.6.1.15;2.6.1.18;2.6.1.21;2.6.1.30;2.6.1.37;2.6.1.40;2.6.1.41;2.6.1.43;2.6.1.44;2.6.1.46;2.6.1.47;2.6.1.51;2.6.1.56;2.6.1.58;2.6.1.66;2.6.1.71;2.6.1.77;2.6.1.84;2.6.1.96;2.6.1.99;2.6.1.108;2.6.1.113;2.6.1.115;2.6.1.119;2.6.3.1;2.7.1.40;2.7.1.121;2.7.3.9;2.7.9.1;2.7.9.2;2.8.1.2;3.1.3.60;3.3.2.1;3.3.2.13;3.3.2.15;3.5.99.10;3.7.1.5;3.7.1.6;3.7.1.20;3.7.1.23;3.7.1.26;3.7.1.-;3.11.1.3;4.1.1.1;4.1.1.64;4.1.1.78;4.1.1.112;4.1.1.-;4.1.2.14;4.1.2.18;4.1.2.20;4.1.2.21;4.1.2.23;4.1.2.28;4.1.2.34;4.1.2.45;4.1.2.51;4.1.2.52;4.1.2.53;4.1.2.54;4.1.2.55;4.1.2.58;4.1.2.64;4.1.2.-;4.1.3.3;4.1.3.16;4.1.3.17;4.1.3.22;4.1.3.25;4.1.3.27;4.1.3.30;4.1.3.32;4.1.3.38;4.1.3.39;4.1.3.40;4.1.3.42;4.1.3.43;4.1.3.44;4.1.3.45;4.1.3.46;4.1.99.1;4.1.99.2;4.2.1.-;4.2.99.20;4.2.99.21;4.3.1.10;4.3.1.13;4.3.1.15;4.3.1.17;4.3.1.18;4.3.1.19;4.3.3.7;4.3.3.8;4.4.1.1;4.4.1.13;4.4.1.15;4.4.1.24;4.4.1.25;4.4.1.28;4.4.1.35;4.4.1.36;4.4.1.-;4.5.1.2;6.4.1.1;7.2.4.2,R00006 R00008 R00014 R00195 R00196 R00197 R00198 R00199;R00200 R00203 R00205 R00206 R00207 R00208 R00209 R00210;R00211 R00212 R00213 R00214 R00215 R00216 R00217 R00218;R00219 R00220 R00221 R00223 R00224 R00226 R00237 R00258;R00297 R00324 R00325 R00344 R00350 R00353 R00368 R00369;R00396 R00398 R00400 R00409 R00430 R00452 R00453 R00470;R00471 R00532 R00543 R00562 R00572 R00576 R00585 R00659;R00666 R00673 R00692 R00703 R00704 R00724 R00728 R00750;R00782 R00906 R00907 R00930 R00985 R00986 R01012 R01031;R01032 R01064 R01085 R01138 R01147 R01148 R01196 R01215;R01261 R01286 R01302 R01335 R01344 R01355 R01447 R01576;R01584 R01645 R01647 R01683 R01699 R01712 R01782 R01784;R01811 R01858 R01874 R02050 R02261 R02271 R02293 R02320;R02408 R02628 R02721 R02754 R02953 R02970 R03001 R03037;R03050 R03081 R03105 R03145 R03277 R03465 R03502 R03528;R03732 R03796 R03854 R04152 R04187 R04350 R04672 R04861;R04941 R05136 R05298 R05538 R05544 R05553 R05605 R05636;R05648 R05652 R05861 R06602 R06603 R06913 R06923 R06934;R07399 R07633 R07634 R07685 R07692 R07713 R08166 R08170;R08197 R08200 R08253 R08570 R08648 R08654 R08660 R08667;R08686 R08698 R08714 R09048 R09088 R09238 R09254 R09366;R10147 R10178 R10180 R10283 R10487 R10527 R10539 R10542;R10550 R10552 R10583 R10597 R10616 R10674 R10691 R10866;R10992 R11023 R11038 R11099 R11141 R11213 R11257 R11352;R11463 R11591 R11593 R11676 R11864 R11996 R12188 R12212;R12237 R12343 R12622 R12689 R12707 R12768 R13049 R13050;R13181 R13209
Trimethylamine,cpd:C00565,"Trimethylamine;(CH3)3N;N,N-Dimethylmethanamine",C3H9N,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism,"Methanogenesis, methylamine/dimethylamine/trimethylamine => methane",NA,1.5.8.2;1.7.2.3;1.14.13.148;1.14.13.239;1.21.4.4;2.1.1.247;2.1.1.250;2.1.1.252;4.3.99.4,R02511 R02560 R04877 R05623 R07228 R09124 R10016 R10017;R10285 R11875 R11911
Valerate,cpd:C00803,Pentanoate;Valerate;Pentanoic acid;Valeric acid;Valerianic acid;n-Pentanoate;n-Valeric acid,C5H10O2,NA,NA,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C00803  Valerate; Pentanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C00803  Pentanoic acid,3.5.1.50,R02938
p-Cresol,cpd:C01468,4-Cresol;p-Cresol;4-Hydroxytoluene;4-Methylphenol,C7H8O,Toluene degradation;Nitrotoluene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Protein digestion and absorption,NA,NA,1.14.13.7;1.14.13.236;1.14.13.-;1.17.9.1;4.1.1.83;4.1.99.19,R02675 R03568 R05666 R07312 R07663 R08041 R10246 R12133
DSS-d6,NA,NA,NA,NA,NA,NA,NA,NA
